<p>Exogenous peptide in the presence of sera at a dilution resulting in approximately 50% inhibition of HCVpp infection (dilutions varied between 1∶50 and 1∶600) was used to test inhibition of genotype 1a HCVpp (A), genotype 1b HCVpp (B), genotype 2a HCVpp(C) and genotype 4 HCVpp (D). Shaded bars and filled bars represent control peptide and peptide 432–443, respectively.</p
<div><p>The humoral immune system responds to chronic hepatitis C virus (HCV) infection by producing...
<p>(A) Neutralizing activity of CHC30was not blocked by peptide 313–327.(B) Neutralizing activity of...
Hepatitis C virus (HCV) is a leading cause of chronic viral hepatitis, but an effective vaccine is s...
It has been reported that monoclonal antibodies (MAbs) to the E1E2 glycoproteins may have the potent...
It has been reported that monoclonal antibodies (MAbs) to the E1E2 glycoproteins may have the potent...
It has been reported that monoclonal antibodies (MAbs) to the E1E2 glycoproteins may have the potent...
<p>Sera obtained 2 weeks after the final immunisation were purified with protein G column and tested...
<p>HCVcc neutralization assays were performed in the presence of diluted 432–443 epitope-reactive sa...
<p>Six samples reactive to epitope 432–443 have cross-genotype neutralizing activity. Serum was asse...
<p>HCVcc neutralization assays were performed in the presence of diluted 313–327 epitope-reactive sa...
Abstract Anti HCV vaccine is not currently available and the present antiviral therapies fail to cur...
<div><p>Currently, there is no effective vaccine to prevent hepatitis C virus (HCV) infection, partl...
Currently, there is no effective vaccine to prevent hepatitis C virus (HCV) infection, partly due to...
The humoral immune system responds to chronic hepatitis C virus (HCV) infection by producing neutral...
<p>%Neutralization is calculated as (1-luciferase value of experimental group/luciferase value of co...
<div><p>The humoral immune system responds to chronic hepatitis C virus (HCV) infection by producing...
<p>(A) Neutralizing activity of CHC30was not blocked by peptide 313–327.(B) Neutralizing activity of...
Hepatitis C virus (HCV) is a leading cause of chronic viral hepatitis, but an effective vaccine is s...
It has been reported that monoclonal antibodies (MAbs) to the E1E2 glycoproteins may have the potent...
It has been reported that monoclonal antibodies (MAbs) to the E1E2 glycoproteins may have the potent...
It has been reported that monoclonal antibodies (MAbs) to the E1E2 glycoproteins may have the potent...
<p>Sera obtained 2 weeks after the final immunisation were purified with protein G column and tested...
<p>HCVcc neutralization assays were performed in the presence of diluted 432–443 epitope-reactive sa...
<p>Six samples reactive to epitope 432–443 have cross-genotype neutralizing activity. Serum was asse...
<p>HCVcc neutralization assays were performed in the presence of diluted 313–327 epitope-reactive sa...
Abstract Anti HCV vaccine is not currently available and the present antiviral therapies fail to cur...
<div><p>Currently, there is no effective vaccine to prevent hepatitis C virus (HCV) infection, partl...
Currently, there is no effective vaccine to prevent hepatitis C virus (HCV) infection, partly due to...
The humoral immune system responds to chronic hepatitis C virus (HCV) infection by producing neutral...
<p>%Neutralization is calculated as (1-luciferase value of experimental group/luciferase value of co...
<div><p>The humoral immune system responds to chronic hepatitis C virus (HCV) infection by producing...
<p>(A) Neutralizing activity of CHC30was not blocked by peptide 313–327.(B) Neutralizing activity of...
Hepatitis C virus (HCV) is a leading cause of chronic viral hepatitis, but an effective vaccine is s...